ZyVersa Therapeutics Inc [NASDAQ: ZVSA] closed the trading session at $3720000.0 on 2025-06-25. The day’s price range saw the stock hit a low of $0.6118, while the highest price level was $0.7299.
The stocks have a year to date performance of -82.34 percent and weekly performance of 10.94 percent. The stock has been moved at -42.74 percent over the last six months. The stock has performed 31.48 percent around the most recent 30 days and changed -1.11 percent over the most recent 3-months.
If compared to the average trading volume of 3.72M shares, ZVSA reached to a volume of 13259151 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about ZyVersa Therapeutics Inc [ZVSA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZVSA shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZVSA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.22, with the Price to Cash per share for the same quarter was set at 0.34.
ZVSA stock trade performance evaluation
ZyVersa Therapeutics Inc [ZVSA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.94. With this latest performance, ZVSA shares gained by 31.48% in over the last four-week period, additionally sinking by -42.74% over the last 6 months – not to mention a drop of -33.02% in the past year of trading.
ZyVersa Therapeutics Inc [ZVSA]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -41.48%, with Return on Assets sitting at -41.48%.
ZyVersa Therapeutics Inc [ZVSA]: Institutional Ownership
There are presently around $7.43%, or 7.45% of ZVSA stock, in the hands of institutional investors.
